Responsiveness of clinical outcome measures in Charcot-Marie-Tooth disease. (Q38979315)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26227902%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

title

Responsiveness of clinical outcome measures in Charcot-Marie-Tooth disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26227902%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26227902%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26227902%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26227902%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26227902%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

M M Reilly

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26227902%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

A Schenone

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26227902%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

G M Fabrizi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26227902%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

T Cavallaro

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26227902%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

L Santoro

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26227902%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

F Manganelli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26227902%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

G Vita

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26227902%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

F Gemignani

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26227902%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

M Laurà

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26227902%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

D Calabrese

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26227902%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

R A C Hughes

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26227902%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

D Radice

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26227902%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

A Solari

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26227902%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

D Pareyson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26227902%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

CMT-TRIAAL Group

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26227902%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

CMT-TRAUK Group

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26227902%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

publication date

31 July 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26227902%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Neurology

20 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26227902%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26227902%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26227902%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

page(s)

1556-1563

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26227902%20AND%20SRC:MED&resulttype=core&format=json

Ascorbic acid for Charcot-Marie-Tooth disease type 1A in children: a randomised, double-blind, placebo-controlled, safety and efficacy trial.

20 February 2020

cites work

1 reference

Effect of ascorbic acid in patients with Charcot-Marie-Tooth disease type 1A: a multicentre, randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

Oral high dose ascorbic acid treatment for one year in young CMT1A patients: a randomised, double-blind, placebo-controlled phase II trial

21 January 2018

1 reference

Ascorbic acid in Charcot–Marie–Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial

21 January 2018

1 reference

Reliability and validity of the CMT neuropathy score as a measure of disability.

21 January 2018

1 reference

The natural history of Charcot-Marie-Tooth type 1A in adults: a 5-year follow-up study

21 January 2018

1 reference

High-dosage ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A: results of a randomized, double-masked, controlled trial

21 January 2018

1 reference

Reliability of clinical outcome measures in Charcot-Marie-Tooth disease

21 January 2018

1 reference

Responsiveness of patient reported outcome measures in multiple sclerosis relapses: the REMS study

21 January 2018

1 reference

On assessing responsiveness of health-related quality of life instruments: guidelines for instrument evaluation.

21 January 2018

1 reference

Are randomized clinical trials good for us (in the short term)? Evidence for a "trial effect".

21 January 2018

1 reference

Reliability of the CMT neuropathy score (second version) in Charcot-Marie-Tooth disease

21 January 2018

1 reference

Psychometrics evaluation of Charcot-Marie-Tooth Neuropathy Score (CMTNSv2) second version, using Rasch analysis

21 January 2018

1 reference

Anterior tibialis CMAP amplitude correlations with impairment in CMT1A.

21 January 2018

1 reference

Natural history of Charcot-Marie-Tooth 2: 2-year follow-up of muscle strength, walking ability and quality of life.

21 January 2018

1 reference

Quality of life in patients with Charcot-Marie-Tooth disease.

21 January 2018

1 reference

Selected items from the Charcot-Marie-Tooth (CMT) Neuropathy Score and secondary clinical outcome measures serve as sensitive clinical markers of disease severity in CMT1A patients.

21 January 2018

1 reference

Diagnosis, natural history, and management of Charcot–Marie–Tooth disease

21 January 2018

1 reference

Minimum clinically important difference in medical studies

21 January 2018

1 reference

Validation of the Charcot-Marie-Tooth disease pediatric scale as an outcome measure of disability

21 January 2018

1 reference

Transitioning outcome measures: relationship between the CMTPedS and CMTNSv2 in children, adolescents, and young adults with Charcot-Marie-Tooth disease

21 January 2018

1 reference

Reliability of instrumented movement analysis as outcome measure in Charcot-Marie-Tooth disease: results from a multitask locomotor protocol

21 January 2018

1 reference

PMP22 messenger RNA levels in skin biopsies: testing the effectiveness of a Charcot-Marie-Tooth 1A biomarker

21 January 2018

1 reference

A rat model of Charcot-Marie-Tooth disease 1A recapitulates disease variability and supplies biomarkers of axonal loss in patients.

21 January 2018

1 reference

Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation

21 January 2018

1 reference

A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): The study protocol [EudraCT no.: 2006-000032-27]

21 January 2018

1 reference